You say you remember ADXS was $0.02 in Decmber 2008, but guess what today i ADXS is still only $0.026 on a split adjusted basis, so despite the Nasdaq uplisting and all the money raised over the last four years, from a shareholder value perspective no value or ROI has been generated for the last nine years.
like many small investors with limited means who own this stock and have great hope for what it offers humanity not to mention the investors..i'm thinking the wait could be coming to an end..commercial validation for LM therapy, start of phase 1 MINE with amgen..EU approval and perhaps followed by approvals in India and asia where adxs is an affordable treatment..but all these posts shout lets focus on near term buyout..not why most of us invested in the first place.
News 
Market Data 
Discover 
AI
